Press Releases

March 7, 2008 - New Perceptronix Medical Inc. test for early-stage oral cancer demonstrated at Pacific Dental Conference [PDF]
Vancouver, BC, March 7, 08 – "Early diagnosis is the most effective way of controlling cancer, and improving the quality of life for patients," says Dr. Bojana Turic, President and CEO of Perceptronix. "Our tests apply advanced automated image cytometry to analyze and evaluate changes in epithelial cells indicative of cancer. The results of early detection tests complement recognized standards of care, enabling timely treatment and encouraging a positive outcome."

February 1 , 2008 - Perceptronix featured at BioPartnering North America [PDF]
Vancouver, BC, February 1, 08 – Perceptronix Medical Inc. (Perceptronix) is pleased to announce its participation at the 6th Annual BioPartnering North America conference, February 3-5, 2008 at the Westin Bayshore in Vancouver, BC. Not only will Perceptronix be represented on the exhibiting floor (Monday, February 4th, 9:45 - 11:45 am) but Dr. Bojana Turic will also highlight Perceptronix' recent developments during her presentation at 3:30 pm the same day.

January 29 , 2008 - Kelowna Figures Prominently in Lung Cancer Research [PDF]
Vancouver, BC, January 29, 08 – Perceptronix Medical Inc. (Perceptronix) was pleased to return to Kelowna, BC on January 24, 2008 to host a special meeting featuring the positive results of an international, multi-centre clinical study for lung cancer in which participants from Kelowna played a significant role.

November 13 , 2007 - Perceptronix to Exhibit at MEDICA 2007 [PDF]
Düsseldorf, Germany, November 13, 07 – As part of their continuing commitment to improving cancer outcomes through earlier detection, Perceptronix Medical Inc. (Perceptronix) will be exhibiting at MEDICA 2007 from November 14 to 17 in Düsseldorf, Germany. Perceptronix will join fellow Canadian companies in the national pavilion (Canada in Hall 3 - Stand 3D64) showcasing the most innovative medical devices our country has to offer to a global audience.

November 8 , 2007 - Perceptronix' Scientists Publish Paper in Journal of Thoracic Oncology [PDF]
Vancouver, BC, November 8, 07 – Perceptronix Medical Inc. (Perceptronix) is pleased to report positive study results from their LungSign™ test for early detection of Lung Cancer. The study, 'Detection of Lung Cancer by Automated Sputum Cytometry' was published in the November 2007 issue of the prestigious Journal of Thoracic Oncology, the official publication of the International Association for the Study of Lung Cancer (IASLC).

November 1 , 2007 - Perceptronix Announces Completion of ClearVu ELITE™ Clinical Study [PDF]
Vancouver, BC, November 1, 07 – Perceptronix Medical Inc. (Perceptronix) announced today the completion of their clinical study entitled "Spectral Imaging of Early Lung Cancer and Pre-cancerous Lesions" using the Company's ClearVu EliteT system.

September 10 , 2007 - Perceptronix announces launch of LungSign™ [PDF]
Vancouver, BC, September 10, 07 – Perceptronix Medical Inc. (Perceptronix) invited local physicians to an informational symposium on Early Detection in Lung Cancer which introduced LungSign™, their product for the early detection of lung cancer, held September 5, 2007 at the Vancouver Art Gallery.

September 2, 2007 - Perceptronix to present clinical trial results at 12th World Conference on Lung Cancer [PDF]
Vancouver, BC, September 2, 07 – Perceptronix Medical Inc. (Perceptronix) announced today they will present results from their clinical trial of LungSign™ at the 12th World Conference on Lung Cancer being held in Seoul, Korea September 2-6, 2007. Dr. David Snead, Consultant Pathologist at Walsgrave NHS Trust Hospital Coventry UK, will introduce the data during his oral presentation scheduled for September 2nd.

June 11, 2007 - Perceptronix selected to present at international forum promoting interdisciplinary collaborations [PDF]
Vancouver, Canada (June 11, 2007) – Dr. Bojana Turic, President and CEO, Perceptronix Medical Inc. (“Perceptronix”) will present at BioDevice Partnering on June 13 at Technopark in Zurich, Switzerland. Dr. Turic would like to invite all those interested in innovative technologies and services for the early detection of cancer to attend her presentation.

June 7, 2007 - Perceptronix launches LungSign.com: providing exciting information on innovative technology that brings new hope to those at risk for lung cancer [PDF]
Vancouver, Canada (June 6, 2007) – Perceptronix Medical Inc. (“Perceptronix”), a private biotechnology company focused on detecting cancer at early stages, is pleased to announce the launch of its new website, www.lungsign.com. LungSign.com is designed to be a primary resource for patients and healthcare providers interested in the early detection of lung cancer.

May 28, 2007 - Perceptronix brings early lung cancer detection to UK by signing service agreement with University Hospital of Coventry and Warwickshire NHS Trust [PDF]
Vancouver, Canada (May 28, 2007) – Perceptronix Medical Inc. (“Perceptronix”) announced it has signed a service agreement for its LungSign™ test (formerly ClearSignTM) with University Hospital of Coventry and Warwickshire (UHCW) NHS Trust in the UK.

April 30, 2007 - Perceptronix invited to present at international conference: Mobilizing the Private Sector for Global Health Development [PDF]
Toronto, Canada (April 30, 2007) – Dr. Bojana Turic, President and CEO, Perceptronix Medical Inc. (“Perceptronix”) has been invited to present at the International Biotechnology Partnership Conference: Mobilizing the Private Sector for Global Health Development on May 2 at the MaRS Centre, Toronto, Ontario. Dr. Turic’s presentation will focus on the company’s approach to addressing the impact smoking-induced cancers are having in developing countries.

April 24, 2007 - Perceptronix appoints Dr. Bojana Turic as new President and Chief Executive Officer [PDF]
Vancouver, Canada (April 24, 2007) – Perceptronix Medical Inc. (“Perceptronix”) announced today that Mr. Carl F. Roy has resigned as President and Chief Executive Officer, effective immediately.  The Board of Directors has appointed Dr. Bojana Turic, MD, Vice President and Chief Operating Officer of Perceptronix, as President and Chief Executive Officer, effectively immediately.

March 14, 2007 - Perceptronix to present at Invest Northwest CEO & Investor Forum [PDF]
Seattle, USA (March 20, 2007) – Dr. Bojana Turic, Vice President, COO will present on behalf of Perceptronix Medical Inc. (“Perceptronix”) at the Invest Northwest CEO & Investor Forum on March 20 at Bell Harbor International Conference Center, Seattle, Washington. 

January 30, 2007 - Perceptronix collaborates with BC Cancer Agency on early oral cancer detection project [PDF]
Vancouver, Canada (January 30, 2007) – Perceptronix Medical Inc. (“Perceptronix”) today announced its participation in a research project to detect early oral cancer lesions through a new initiative inside the BC Oral Cancer Prevention Program. This Program is bringing together a network of dentists, researchers and technology companies to develop early screening programs for oral cancer.

January 19, 2007 - Perceptronix appoints Ms. Rohini Hira, Vice President Sales and Marketing [PDF]
Vancouver, Canada (January 19, 2007) – Perceptronix CEO Carl Roy announced the appointment of Ms. Rohini Hira to the position of Vice President Sales and Marketing effective December 15th, 2006. Ms. Hira has the vision and experience to commercialize Perceptronix’s early cancer detection products and services in Canada, the US and the EU.  
 
Archived Press Releases